Effect of Yiqibushenhuoxue decoction on chronic obstructive pulmonary disease measured by St. George's respiratory disease questionnaire scores and forced expiratory volume

Journal of Traditional Chinese Medicine

Volumn 34, Issue 4, 2014, Pages 445-449

  Liu, Jianqiu ^a   Gao, Fengli ^a   Li, Zhuying ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Airway inflammation; Chronic obstructive; Pulmonary disease; Quality of life; Yiqibushenhuoxue decoction

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; YIQIBUSHENHUOXUE DECOCTION; HERBACEOUS AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; ST. GEORGE RESPIRATORY QUESTIONNAIRE; AGED; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME;

AGED; DRUGS, CHINESE HERBAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84907404188     PISSN: 02552922     EISSN: 2589451X     Source Type: Journal    
DOI: 10.1016/s0254-6272(15)30044-3     Document Type: Article

References (13)

1. GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Revised 2011), 2011-12-30, cited 2013-09-02. Available from URL: http://www.goldcopd.org/uploads/users/files/GOLD2011-Summary.pdf.
2. Wen FQ. The complexity of inflammatory reaction in chronic obstructive pulmonary disease and new treatment options. Zhong Hua Zhong Yi Yao Za Zhi 2012; 35(4): 246-248.
3. Society of chronic obstructive pulmonary disease, Branch Association of Respiratory Disease, Chinese Medical Association. Guide to diagnosis and treatment of chronic obstructive pulmonary disease (revision, 2007). Zhong Hua Jie He He Hu Xi Za Zhi 2007; 30(1): 8-17.
4. Li JS, Li SY, Yu XQ. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease with Traditional Chinese Medicine. Zhong Yi Za Zhi 2012; 53(1): 80-84.
5. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991; 85(Supplement 2): 25-31.
6. Li JS, Yu XQ, Wang MH, Li SY, Wang ZW. The strategy and practice of the research on the treatment of chronic obstructive pulmonary disease with Traditional Chinese Medicine. Zhong Hua Zhong Yi Yao Za Zhi 2012; 27(6): 1607-1614.
7. Li J, Wang Q, Wu WP, Cui HS, Ye YA. Analysis of chronic obstructive pulmonary disease about pathogenesis evolution combining with the GOLD grading. Beijing Zhong Yi Yao Da Xue Xue Bao 2005; 12(6): 8-11.
8. Zhou W, Zhong YQ, Yang HM, et al. Systematic review of randomized controlled trials which are about the treatment of chronic obstructive pulmonary disease in stable period with Traditional Chinese Medicine. Zhong Guo Xun Zheng Yi Xue Za Zhi 2009; 9(3): 311.
9. Feng PP, Li ZX, Yuan Z. Research progress of chemical constituents and pharmacological activities of Codonopsis pilosula medicinal plants. Shenyang Yao Ke Da Xue Xue Bao 2012; 29 (4): 307-310.
10. Du Q, Chen Z, Zhou LF, Zhang Q, Huang M, Yin KS. Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma. Can J Physiol Pharmacol 2008; 86(7): 449-457.
11. Shen XF, Jin H. Pharmacological channel tropism of astragalus and codonopsis pilosula, and their clinical application. Shi Yong Nei Ke Za Zhi 2012; 26(7): 75, 77.
12. Cao YX, Dong JC, Cui Y. Characteristics of airway inflammation in rats with chronic obstructive pulmonary disease and asthma and the interventional study with Chinese herbs for replenishing Shen and strengthening Qi. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2009; 28(8): 716-721.
13. Zhang Q, Yang JF, Shi HJ. Progess in studied on pharmacological effect of Caesalpinia sappan L. Zhong Guo Zhong Yi Ji Zheng 2013; 22(3): 419-421.